After SREBP2 knockout in tumor cells or simvastatin treatment, we observed that these interventions significantly promoted NK cell‐mediated cytotoxicity against gastric cancer in vivo and prolonged the survival of tumor‐bearing mice (Fig. 6A,B). This evidence concerns the gene SREBF2 and gastric cancer.